On February 26, 2010
Heart Association Finds Drug Risks “Inconclusive” After Taking $3.6M From Its Maker Glaxo
The American Heart Association said that the data are “inconclusive” on whether GlaxoSmithKline (GSK)’s diabetes drug Avandia carries an increased risk of heart problems. But the organization’s statement does not disclose the fact that GSK gave AHA more than $3.5
…
0 Comments